期刊文献+

他克莫司、霉酚酸酯和甲基强的松龙联合治疗慢性移植物抗宿主病 被引量:4

Tacrolimus, mycophenolate mofetil combined with methylprednisone in treating chronic graft-versus-host disease
暂未订购
导出
摘要 目的 探讨他克莫司 (FK50 6 )、霉酚酸酯 (MMF)和甲基强的松龙 (MP)联合免疫抑制剂治疗慢性移植物抗宿主病 (cGVHD)的疗效。方法 对 4例异基因造血干细胞移植后发生广泛性cGVHD的儿童患者 ,应用FK50 6 ,MMF和MP联合治疗 ,观察其毒副作用和疗效。结果  4例患者使用该联合免疫抑制方案治疗 2~ 4d后症状明显改善 ,1~ 2周后症状消失 ,有效率达 1 0 0 %。除 3例出现轻度肾功能损害外 ,未发现严重副作用。结论 FK50 6 ,MMF和MP联合治疗cGVHD为一种行之有效的方法。 Objective To investigate the efficacy of tacrolimus (FK506), mycophenolate mofetil (MMF) combined with methylprednisone (MP) for the treatment of chronic graft-versus-host disease (cGVHD) Methods 4 children with extensive cGVHD after allogeneic stem cell transplantation were treated with the combination of FK506, MMF and MP Results All patients improved significantly after 2~4 days, and the signs of cGVHD disappeared after 1~2 weeks The total effective rate was 100% No serious side effects were observed except mild renal function damage in 3 patients Conclusion Combined immunosuppression with FK506, MMF and MP is feasible for the treatment of cGVHD
出处 《广东医学》 CAS CSCD 2001年第8期659-661,共3页 Guangdong Medical Journal
关键词 慢性移植物抗宿主病 他克莫司 霉酚酸酯 甲基强的松龙 Chronic graft-versus-host disease\ Tacrolimus\ Mycophenolate mofetil\ Methylprednisone
  • 相关文献

参考文献4

二级参考文献1

共引文献11

同被引文献21

  • 1刘启发,范志平,孙竞,易正山,徐丹,张钰,魏永强,叶昌雄,杨凯,孟凡义.两种方案预防无血缘关系供者造血干细胞移植后移植物抗宿主病的效果比较[J].中华血液学杂志,2006,27(8):550-552. 被引量:4
  • 2Sullivan KM. Graft-versus-host disease[ M ].Thomas ED. Hematopoietic Cell Transpalntation. 2^nd ed. Malden: Blackwell Science Inc,USA,1999:515.
  • 3Basara N, Baurmann H, Kolbe K, et al. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: resuits from the muticenter German cooperative study group [ J ]. Bone Marrow Transplantation ,2005,35 (7) : 1011.
  • 4Ballen KK. New trends in umbilical cord blood transplantation [ J]. Blood,2005,105 (10) :3786.
  • 5Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors[ J] . N Engl J ned,1998,339(22) :1565.
  • 6Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors[ J]. N Engl J MED, 1997,337 (6) :373.
  • 7Fang JP, Huang SI, Chen C, et al. Umbilical cord blood transplantation in Chinese children with beta-thalassemia[ J]. J Pediatr Hematol Oncol, 2004,26 (3) : 185.
  • 8Gaziev D, Lucarelli G. Novel approaches to the treatment of chronic graft-versus-host disease. Expert Opin Investig Drugs ,2001,10:909-923.
  • 9Nagler A, Menachem Y, Ilan Y. Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment. J Hematother Stem Cell Res ,2001,10:411-417.
  • 10Akpek G, Zahurak ML, Piantadosi S, et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood, 2001,97:1219-1226.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部